Key result
Review highlights calcific aortic valve stenosis pathogenesis, sensitive valve calcification markers, and emerging therapies.
Why the study?
Calcific aortic valve stenosis lacks effective treatments to prevent or delay progression, and traditional hemodynamic markers may fail to detect early, potentially modifiable disease.
The review highlights the pathophysiologic drivers of calcific aortic valve stenosis and underscores the need for novel medical therapies and sensitive markers like aortic valve calcification to track early disease progression.
Answers are grounded in this paper and cite their sources.
May improve early calcific AS monitoring with valve calcification; leaves open efficacy of novel therapies pending RCTs.
Calcific aortic valve stenosis (CAVS) is the most frequent valve disorder in adults, with a steadily increasing incidence with age. Currently, no effective treatments are available to prevent or delay disease progression. In addition to progressive calcification, there is increasing recognition of the underlying roles of oxidative stress, chronic inflammation, lipoprotein deposition, and induction of osteogenic signaling in driving progression of CAVS. Although traditional markers of CAVS progression, such as increased valve gradients and reduced areas, are currently used to guide clinical decisions regarding valve replacement, these measures may not capture progression of early, potentially modifiable disease. Hence, there is a need for more sensitive markers, such as aortic valve calcification, to monitor disease progression in CAVS. This JACC State-of-the-Art Review provides a comprehensive discussion of the pathogenesis and progression of CAVS and emphasizes the unmet need for innovative medical treatments. Additionally, it explores emerging therapeutic approaches, advanced methods for evaluating disease progression, and cutting-edge techniques to measure therapeutic efficacy.
No takes yet. Share an insight, caveat, or question.
Desai et al. (2025) conducted a review in Calcific aortic valve stenosis. This state-of-the-art review highlights the pathogenesis of calcific aortic valve stenosis, the need for sensitive markers like valve calcification, and emerging therapeutic approaches.
Synapse has enriched 10 related papers. Consider them for comparative context: